Clinical Trials Directory

Trials / Unknown

UnknownNCT02084550

Amino Acids in Ileal Pouch-anal Anastomosis for Ulcerative Colitis

Amino Acids in Ileal Pouch-anal Anastomosis for Ulcerative Colitis: a Randomized, Assessor-blinded, Placebo-controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
8 (estimated)
Sponsor
Aarhus University Hospital · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The detrimental effects of catabolism, insuline resistance and muscle wasting on surgical outcome is wellknown. This catabolism is especially pronounced in patients with acute or chronic inflammation (IBD, cancer) and for those undergoing major surgery. Patients with ulcerative colitis operated with an ileal pouch-anal anastomosis (j-pouch) fall well into both these categories. To prevent this undesirable catabolism, we will investigate the effects of intravenous administration of predominantly anabolic amino acids (with an amino acid content equal to breast milk) on whole body metabolism, with special emphasis on muscle and fat metabolism and intracellular signalling pathways. Twenty-four patients will be block-randomized by gender in this parallel-group, randomized, assessor-blinded, placebo-controlled trial to receive either Vaminolac® (Fresenius Kabi) or saline. Metabolism before and after the intervention will be assessed by palmitate- and amino acid kinetics of radioactively labelled tracers, while muscle and fat biopsies will be analyzed for differences in intracellular signaling pathways (PI3 kinase, Akt, etc.) as a measure of cellular activity. With this study we hope to find evidence for anabolic effects of intravenous amino acids in j-pouch surgery for ulcerative colitis. The perspective is a potential for primary prophylaxis of surgical complications, reduction in the length of hospitalization, and subsequently optimized long-term functional outcome of the pouch.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVaminolacVaminolac with an amino acid content corresponding humane breast milk.
OTHERSalineIntravenous isotonic saline with a sodium chloride content of 9mg/ml.

Timeline

Start date
2015-09-01
Primary completion
2017-07-01
Completion
2017-09-01
First posted
2014-03-12
Last updated
2017-07-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02084550. Inclusion in this directory is not an endorsement.